Ekaterina Viteva
Medical University Plovdiv, Bulgaria
Title: Recurrent Seizures in Hospitalized Patients with Status Epilepticus: Risk Factors and Role for Outcome
Submitted Date: 8/26/2015
Biography
E Viteva studied at Medical University–Plovdiv, Department of Neurology. She is a member of the Bulgarian Neurological Society, the Bulgarian Association of neurosonology, the Bulgarian society of Child Neurology, Psychiatry and Psychology of Development.
Abstract
Introduction: The rate of seizure recurrence is an important aspect of short-term outcome in patients with status epilepticus (SE) which has received scarce attention by few studies.Purpose: Our purpose was to identify the risk factors for recurrent seizures during hospitalization of patients with SE and the role of seizure recurrence for functional outcome.Methods: We performed a prospective study of 95 consecutive patients diagnosed with SE and treated in a neuro-intensive care unit over a period of 3 years. Demographics and clinical data concerning established epilepsy and SE were collected and their relationship to the rate of seizure recurrence was analyzed. SE functional outcome assessment was based on the results from the Glasgow Outcome Scale. Results: There were single seizures in 26 (27.37) of our study participants after SE management, in 15 (15.79%) patients recurrent clusters of seizures or SE were observed. The rate of seizure recurrence was significantly higher in participants with longer duration of prior epilepsy and SE, SE poly therapy, recurrent SE, established epilepsy with polymorphic seizures, poor compliance and inadequate antiepileptic treatment. On multivariate regression analysis the predictive role of prior epilepsy duration and SE duration for seizure recurrence was confirmed P<0.001 (F=14.52). No correlation was found between the rate of seizure recurrence and functional outcome P>0.05. Conclusion: The study confirms the role of some clinical factors for the rate of seizure recurrence in hospitalized patients with SE and denies the direct association of seizure recurrence with functional outcome. Our results may be useful for finding more successful management strategies of the post-SE period.
Gavzandarounkola Hakimeh
University of Tehran, Iran
Title: Synergistic Effect of Docosahexaenoic Acid on The Anticonvulsant Activity of Lamotrigine in Amygdala Kindling Seizure Model
Submitted Date: 8/26/2015
Biography
Gavzandarounkola Hakimeh had completed her B.V.M at the age of 24 years from Shahid Chamran University and PhD of physiology at the age of 29 years from Tehran University Faculty of Veterinary. Her PhD thesis was “Evaluation of behavioral and electrophysiological effects of the unsaturated fatty acid DHA in experimental model of seizures. She performed her PhD thesis in Pasteur Institute of Iran, Tehran. She is teaching physiology in Amol University of special modern technology. She had 2 papers; “Effect of Echinacea purpurea on antibody production against fowl influenza “and “Synergistic effect of docosahexaenoic acid on anticonvulsant activity of valproic acid and lamotrigine in animal seizure modelâ€. Also she had given several oral presentations and posters in some international conferences.
Abstract
Introduction: Combination therapy is a common strategy to increase the efficacy and decrease side effects of antiepileptic drugs. Considerable anticonvulsant potential as well as appropriate safety of Docosahexaenoic acid (DHA) makes it a good candidate for combination therapy. In this study, we evaluated the influence of DHA on the anticonvulsant activity of one of the common antiepileptic drugs (AEDs), lamotrigine, in the kindling model of epilepsy in rats.rnrnMethods: Dose-antiseizure curve for lamotrigine (60 min after i.p. injection of doses 10, 12.5, 15, and 20 mg/kg to rats) against complex partial seizures induced by amygdala-rapid kindling was obtained. DHA was injected at doses 1, 300 and 1000μM in kindling model and DHA anti-seizure effect examined in this model, 15 min after intracerebroventricular (i.c.v.) injection.. Then a non-protective dose of DHA 300μM (ED25) was added to increasing doses of lamotrigine and new dose-antiseizure curve was obtained.Results and conclusion: DHA showed dose-dependent protective effect against kindled seizure (1087.824 μM). DHA at ED25 caused 4.938 fold increases in potency of Lamotrigine (ED50 value from 13.10 decreased to 2.65 mg/kg). Compusyn analysis indicated synergistic anticonvulsant interaction between DHA and Lamotrigine. As a result, Co-administration of the safer and inexpensive anticonvulsant agent DHA, with common AEDs can be considered as a good strategy in the treatment of epilepsy.